Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

168 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.
Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ; VIGOR Study Group. Bombardier C, et al. Among authors: ferraz mb. N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103. N Engl J Med. 2000. PMID: 11087881 Clinical Trial.
Response to expression of concern regarding VIGOR study.
Bombardier C, Laine L, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ, Weaver A. Bombardier C, et al. Among authors: ferraz mb. N Engl J Med. 2006 Mar 16;354(11):1196-9. doi: 10.1056/NEJMc066096. Epub 2006 Feb 22. N Engl J Med. 2006. PMID: 16495387 No abstract available.
The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs.
Maetzel A, Ferraz MB, Bombardier C. Maetzel A, et al. Among authors: ferraz mb. Arthritis Rheum. 1998 Jan;41(1):16-25. doi: 10.1002/1529-0131(199801)41:1<16::AID-ART3>3.0.CO;2-4. Arthritis Rheum. 1998. PMID: 9433865
A summary of economic evaluations published in the field of rheumatology and related disciplines.
Ferraz MB, Maetzel A, Bombardier C. Ferraz MB, et al. Arthritis Rheum. 1997 Sep;40(9):1587-93. doi: 10.1002/art.1780400907. Arthritis Rheum. 1997. PMID: 9324012
A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis.
Ferraz MB, O'Brien B. Ferraz MB, et al. J Rheumatol. 1995 May;22(5):908-14. J Rheumatol. 1995. PMID: 8587081
Development and testing of a decision board to help clinicians present treatment options to lupus nephritis patients in Brazil.
De Abreu MM, Gafni A, Ferraz MB. De Abreu MM, et al. Among authors: ferraz mb. Arthritis Rheum. 2009 Jan 15;61(1):37-45. doi: 10.1002/art.24368. Arthritis Rheum. 2009. PMID: 19116966
A review of cost-effectiveness analyses in rheumatology and related disciplines.
Maetzel A, Ferraz MB, Bombardier C. Maetzel A, et al. Among authors: ferraz mb. Curr Opin Rheumatol. 1998 Mar;10(2):136-40. doi: 10.1097/00002281-199803000-00009. Curr Opin Rheumatol. 1998. PMID: 9567209 Review.
[A short-term randomized controlled study with methotrexate in rheumatoid arthritis].
Pinheiro GR, Helfenstein Júnior M, Ferraz MB, Atra E. Pinheiro GR, et al. Among authors: ferraz mb. Rev Assoc Med Bras (1992). 1993 Apr-Jun;39(2):91-4. Rev Assoc Med Bras (1992). 1993. PMID: 8242109 Clinical Trial. Portuguese.
Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial.
Ferraz MB, Pinheiro GR, Helfenstein M, Albuquerque E, Rezende C, Roimicher L, Brandao L, Silva SC, Pinheiro GC, Atra E. Ferraz MB, et al. Scand J Rheumatol. 1994;23(5):231-6. doi: 10.3109/03009749409103721. Scand J Rheumatol. 1994. PMID: 7973475 Clinical Trial.
Resource utilization and cost of rheumatic fever.
Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilário MO. Terreri MT, et al. Among authors: ferraz mb. J Rheumatol. 2001 Jun;28(6):1394-7. J Rheumatol. 2001. PMID: 11409136
168 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback